眼缺血综合征国内外文献特征分析

doi:10.6040/j.issn.1673-3770.1.2020.044

Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2020, Vol. 34 ›› Issue (4): 35-40.doi: 10.6040/j.issn.1673-3770.1.2020.044

Previous Articles Next Articles

Analysis of the literature on ocular ischemic syndrome at home and abroadMENG Bo, HUANG Yingxiang, WANG Kang, ZHAO Lu, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:

ObjectiveObjectiveTo analyze the literature on ocular ischemic syndrome published between January 1, 2014 and December 31, 2019. MethodPapers on OIS that were published between January 1, 2014 and December 31, 2019, were screened and retrieved from the CNKI and WOS databases, and those that were relevant were searched and analyzed. ResultsIn this analysis, 35 Chinese papers on OIS were cited for 41 times with an h-index of 2, while 48 foreign papers were cited for 115 times with an h-index of 6. Of the organizations that published the highest number of papers and had the highest h-indexes, the Capital Medical University and the Polish Medical University of Pomerania were the leading institutions. The Chinese Journal of Ophthalmology was the leading domestic journal, and the Journal of Ophthalmology and Plos One were the leading foreign journals. China published the highest number of papers abroad; China and South Korea had the highest h-indexes. China′s National Natural Science Foundation provided the most support to the field of OIS, accounting for 20.8% of the total domestic literature. The most frequently cited article in the WOS database was by Hayreh, SS, which was on the prevalence and pathogenesis of ocular vascular occlusive disease and melanosis; it was also part of the top ten studies that focused on the utility of OCT in providing insights into OIS and the mechanisms of ischemia and hypoxia. ConclusionThe utility of OCT in providing insights into OIS and the mechanisms of hypoxia and ischemia represents a modern focus of researchers.

Key words:Ocular ischemic syndrome;
Eye;
H factor;
Citation眼缺血综合征(ocular ischemic syndrome, OIS)是由颈动脉狭窄或闭塞引起的眼部血液循环障碍或灌注不足性疾病。患者就诊时常主诉视力下降及眼球或眼眶疼痛。该病主要见于50岁以上老年人, 发病原因包括动脉粥样硬化、炎症、外伤、手术等, 发病危险因素包括高血压、糖尿病、高脂血症等^［1-3］。本文从文献计量学的角度, 在前期引文分析的基础上^［4］, 对国内外数据库中2014~2019年发表的OIS领域相关文献进行了特征分析, 旨在揭示近些年该领域研究在作者、机构、期刊、国家、国内基金资助情况等层面的数量分布特征和发展趋势。希望学者们通过本文的分析能对OIS的发展动态有所掌握, 便于开展OIS相关研究。

Received:2020-05-22 Online:2020-07-20 Published:2020-08-28

Abstract

Abstract: Objective Objective To analyze the literature on ocular ischemic syndrome published between January 1, 2014 and December 31, 2019. Method Papers on OIS that were published between January 1, 2014 and December 31, 2019, were screened and retrieved from the CNKI and WOS databases, and those that were relevant were searched and analyzed. Results In this analysis, 35 Chinese papers on OIS were cited for 41 times with an h-index of 2, while 48 foreign papers were cited for 115 times with an h-index of 6. Of the organizations that published the highest number of papers and had the highest h-indexes, the Capital Medical University and the Polish Medical University of Pomerania were the leading institutions. The Chinese Journal of Ophthalmology was the leading domestic journal, and the Journal of Ophthalmology and Plos One were the leading foreign journals. China published the highest number of papers abroad; China and South Korea had the highest h-indexes. China's National Natural Science Foundation provided the most support to the field of OIS, accounting for 20.8% of the total domestic literature. The most frequently cited article in the WOS database was by Hayreh, SS, which was on the prevalence and pathogenesis of ocular vascular occlusive disease and melanosis; it was also part of the top ten studies that focused on the utility of OCT in providing insights into OIS and the mechanisms of ischemia and hypoxia. Conclusion The utility of OCT in providing insights into OIS and the mechanisms of hypoxia and ischemia represents a modern focus of researchers.

Key words: Ocular ischemic syndrome, Eye, H factor, Citation

CLC Number:

R774.5

ObjectiveObjectiveTo analyze the literature on ocular ischemic syndrome published between January , and December , . MethodPapers on OIS that were published between January , and December , , were screened and retrieved from the CNKI and WOS databases, and those that were relevant were searched and analyzed. ResultsIn this analysis, Chinese papers on OIS were cited for times with an h-index of , while foreign papers were cited for times with an h-index of . Of the organizations that published the highest number of papers and had the highest h-indexes, the Capital Medical University and the Polish Medical University of Pomerania were the leading institutions. The Chinese Journal of Ophthalmology was the leading domestic journal, and the Journal of Ophthalmology and Plos One were the leading foreign journals. China published the highest number of papers abroad, China and South Korea had the highest h-indexes. China′s National Natural Science Foundation provided the most support to the field of OIS, accounting for .% of the total domestic literature. The most frequently cited article in the WOS database was by Hayreh, SS, which was on the prevalence and pathogenesis of ocular vascular occlusive disease and melanosis, it was also part of the top ten studies that focused on the utility of OCT in providing insights into OIS and the mechanisms of ischemia and hypoxia. ConclusionThe utility of OCT in providing insights into OIS and the mechanisms of hypoxia and ischemia represents a modern focus of researchers.. Analysis of the literature on ocular ischemic syndrome at home and abroadMENG Bo, HUANG Yingxiang, WANG Kang, ZHAO Lu, WANG Yanling Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, ChinaAbstract:[J].Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 35-40.

References 21

[1]	Mendrinos E, MacHinis TG, Pournaras CJ. Ocular ischemic syndrome[J]. Surv Ophthalmol, 2010, 55(1): 2-34. doi:10.1016/j.survophthal.2009.02.024.
[2]	Peter J, David S, Danda D, et al. Ocular manifestations of Takayasu arteritis: a cross-sectional study[J]. Retina(Philadelphia, Pa), 2011, 31(6): 1170-1178. doi:10.1097/IAE.0b013e3181fe540b.
[3]	秦亚丽, 冀美琦, 金明. 眼缺血综合征的研究进展[J]. 中国中医眼科杂志,2019,29(5):412-415. doi:10.13444/j.cnki.zgzyykzz.2019.05.020. QIN Yali,JI Meiqi,JIN Ming.Recent advances on ocular ischemic syndrome[J]. Chinese Journal of Chinese Ophthalmology, 2019,29(5):412-415. doi:10.13444/j.cnki.zgzyykzz.2019.05.020.
[4]	王昱, 刘喆, 王艳玲. 眼缺血综合征引文分析[J]. 中华眼科杂志,2014,50(12):906-910. doi:10.3760/cma.j.issn.0412-4081.2014.12.007. WANG Yu,LIU Zhe,WANG Yanling.Citation analysis of the ocular ischemic syndrome literature[J]. Chinese Journal of Ophthalmology,2014,50(12):906-910. doi:10.3760/cma.j.issn.0412-4081.2014.12.007.
[5]	杨华, 徐洪斌. 三种眼科学期刊引文分析[J]. 中华眼科杂志, 2007(10): 932-935. doi:10.3760/j.issn:0412-4081.2007.10.015 YANG Hua, XU Hongbin. Citation analysis of three ophthalmology journals[J]. Chinese Journal of Ophthalmology, 2007(10): 932-935. doi:10.3760/j.issn:0412-4081.2007.10.015.
[6]	万锦堃, 花平寰, 宋媛媛, 等. h指数及其用于学术期刊评价[J]. 评价与管理, 2006, 4(3): 1-7.
[7]	徐晓泉, 毛文明, 郑俊海, 等. 我国眼科学术期刊学术水平与影响力分析[J]. 中华眼科杂志, 2009(4): 361-366. doi:10.3760/cma.j.issn.0412-4081.2009.04.015. XU Xiaoquan, MAO Wenming, ZHENG Junhai, et al. Analysis of the academic level and impact of ophthalmolgical periodicals in China[J]. Chinese Journal of Ophthalmology, 2009(4): 361-366. doi:10.3760/cma.j.issn.0412-4081.2009.04.015.
[8]	郭中晓, 赵蕾. 《中华眼底病杂志》2006至2008年引文计量分析[J]. 中华眼底病杂志, 2010(5): 477-480.
[9]	吴琨芳, 文峰. 中华眼科杂志2000至2009年刊出论文的影响因子和被引频次分析[J]. 中华眼科杂志, 2011(8): 738-742. doi:10.3760/cma.j.issn.0412-4081.2011.08.015 WU Kunfang, WEN Feng. The impact factor and citation frequency of Chinese Journal of Ophthalmology from 2000 to 2009[J]. Chinese Journal of Ophthalmology, 2011(8): 738-742. doi:10.3760/cma.j.issn.0412-4081.2011.08.015
[10]	Heßler H, Zimmermann H, Oberwahrenbrock T, et al. No evidence for retinal damage evolving from reduced retinal blood flow in carotid artery disease[J]. Biomed Res Int, 2015, 2015: 604028. doi:10.1155/2015/604028.
[11]	Kang HM, Lee CS, Lee SC. Thinner subfoveal choroidal thickness in eyes with ocular ischemic syndrome than in unaffected contralateral eyes[J]. Albrecht Von Graefes Arch Fur Klinische Und Exp Ophthalmol, 2014, 252(5): 851-852. doi:10.1007/s00417-014-2609-3.
[12]	Kim DY, Joe SG, Lee JY, et al. Choroidal thickness in eyes with unilateral ocular ischemic syndrome[J]. J Ophthalmol, 2015, 2015: 620372. doi:10.1155/2015/620372.
[13]	Sayin N, Kara N, Uzun F, et al. A quantitative evaluation of the posterior segment of the eye using spectral-domain optical coherence tomography in carotid artery Stenosis: a pilot study[J]. Ophthalmic Surg Lasers Imaging Retina, 2015, 46(2): 180-185. doi:10.3928/23258160-20150213-20.
[14]	Willerslev A, Li XQ, Cordtz P, et al. Retinal and choroidal intravascular spectral-domain optical coherence tomography[J]. Acta Ophthalmol, 2014, 92(2): 126-132. doi:10.1111/aos.12048.
[15]	Hayreh SS, Zimmerman MB. Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses[J]. Retina(Philadelphia, Pa), 2014, 34(1): 115-122. doi:10.1097/IAE.0b013e31829234b5.
[16]	Jeong YC, Hwang YH. Etiology and features of eyes with rubeosis iridis among Korean patients: a population-based single center study[J]. PLoS One, 2016, 11(8): e0160662. doi:10.1371/journal.pone.0160662.
[17]	Chen CS, Miller NR. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management[J]. Compr Ophthalmol Update, 2007, 8(1): 17-28.
[18]	Masuda T, Shimazawa M, Hara H. The kallikrein system in retinal damage/protection[J]. Eur J Pharmacol, 2015, 749: 161-163. doi:10.1016/j.ejphar.2014.10.007.
[19]	Du R, Wang JL, Wang YL. Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(11): 2217-2226. doi:10.1007/s00417-016-3456-1.
[20]	Avery MB, Magal I, Kherani A, et al. Risk of stroke in patients with ocular arterial occlusive disorders: a retrospective Canadian study[J]. J Am Heart Assoc, 2019, 8(3): e010509. doi:10.1161/JAHA.118.010509.
[21]	赵霞, 李双农. 阻塞性睡眠呼吸暂停低通气综合征与缺血性眼病的相关性研究[J]. 中国中医眼科杂志, 2016, 26(1): 58-61. doi:10.13444/j.cnki.zgzyykzz.2016.01.016. ZHAO Xia, LI Shangnong. Relationship between obstructive sleep apnea hyponea syndrome and ischemic ophthalmopathy[J]. Journal of Traditional Chinese Ophthalmology, 2016, 26(1): 58-61. doi:10.13444/j.cnki.zgzyykzz.2016.01.016.

Related Articles 15

[1]	LI Kai, LUO Dan. Runmu ling formula ameliorates ocular surface damage in dry eye rats by activating the LC3-ATG5 autophagy pathway and inhibiting inflammatory factor expression [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 92-101.
[2]	YANG Guanying, LI Yuanbin. Advances in the application of artificial intelligence to dry eye disease management [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 115-120.
[3]	WU Fulian, JI Xuying. Layer-specific response distribution characteristics of binaural integration neurons in the auditory cortex and synaptic input regulation mechanism [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 7-17.
[4]	FANG Lu, LEI Yudan, WANG Hua. Meta-analysis of clinical effect of cyclosporine eye drops in combination with sodium hyaluronate eye drops in the treatment of dry eye syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 65-73.
[5]	NING Yuyun, LI Tong, ZHANG Xinxin. Topical pharmacologic treatment of dry eye disease associated with meibomian gland dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(2): 125-132.
[6]	ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[7]	LI Yuchen, WANG Xu. The efficacy and safety of scleral lenses in treating severe ocular surface disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 149-154.
[8]	QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77.
[9]	LIU Xin, DU Anshi, WANG Yan, TAN Qingqing, LI Junping, GUO Yunan, LAN Changjun. Investigation of the correlation between levator palpebrae superioris muscle strength and postoperative eyelid closure in patients with blepharoptosis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 70-75.
[10]	HUANG Qi, DENG Xuwen, WANG Peipei, CHEN Yequn, GU Xuejun. Research on evaluating the cataract surgery level of ophthalmologists using eyeSi surgical simulator [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 83-88.
[11]	GU Yuelong, TANG Ru, MAO Song, ZHANG Weitian. Predictive value of postoperative GH and IGF-1 levels for long-term remission in non-invasive growth hormone-secreting pituitary adenoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 45-50.
[12]	YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[13]	CHEN Liqun, HALIMUBIEKE Shamali, WANG jing, WANG Fujiang, Yi Xianglong. Changes of ocular surface parameters of digital eye strain and its prevention and mitigation measures [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 177-182.
[14]	ZHANG Guoming, WEI Wenbin, LIN Haotian, CHI Wei, ZHANG Shaochong, ZHAO Peiquan, LEI Baiying, CHEN Youxin, WANG Yusheng, HE Mingguang, LIANG Jianhong, LU Hai, LU Fang, HUANG Xin, LIANG Xiaoling, ZHAO Xinyu, WU Zhenquan, YU Zhen, CUI Kaixuan, LIU Yaling, XIANG Daoman, CHEN Changzheng, ZHANG Zifeng, LIN Duoru, YU Shanshan, SUN Yue, TAN Tao, CHEN Yanxian, PENG Jie, DONG Li, CHENG Yong, ZHU Xuemei, YANG Peng, CHEN Shaobin. Expert consensus on AI-assisted diagnosis and treatment of retinopathy of prematurity(2025) [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 1-5.
[15]	LUO Lu, ZHOU En, XIAO Xuping, LIN Zhiqiang, FANG Zhijie, LYU Xiaohong. Application of plasma pointlike excitation technology in children with obstructive sleep apnea undergoing tonsillectomy and adenoidectomy combined with perioperative enhanced recovery after surgery program [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 26-30.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 0

No Suggested Reading articles found!